Search the Newsreel

Responsive Playbooks and the ETON Inflection

This article provides an AI-driven analysis for Eton Pharmaceuticals Inc. (NASDAQ: ETON), highlighting weak near and mid-term sentiment but a positive long-term outlook. It details specific trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report suggests …

Rigel Pharmaceuticals (RIGL) Stock Sees Fair Value Lift As Veppanu Launch Adds Growth Hope

Rigel Pharmaceuticals (RIGL) has seen its fair value estimate increase from US$51.6 to US$61.2 per share, primarily due to the launch of Veppanu in the U.S. and the international potential of Rezlidhia through a partnership with Kissei. Analysts, such as H.C. Wainwright, view Veppanu …

Why Eton Pharmaceuticals (ETON) Is Up 32.0% After Q2 Earnings Surge And Raised 2026 Outlook

Eton Pharmaceuticals (ETON) saw its stock rise 32.0% after reporting a significant Q2 2026 earnings turnaround, with revenue surging to US$37.59 million and net income reaching US$11.58 million. The company also raised its full-year 2026 revenue guidance to at least US$145 million and expanded …

Enterprise value to revenue forward of Rhythm Pharmaceuticals, Inc. – DUS:1RV

This article provides financial data for Rhythm Pharmaceuticals, Inc. (DUS:1RV) on the Dusseldorf Stock Exchange, specifically focusing on its enterprise value to revenue forward. It notes that the market is closed with no trades recorded at the time of publication. The content is presented …

York Space Systems (YSS) Stock Hit By Revenue Reset Despite Strong Backlog

Price to book forward of Howmet Aerospace Inc. – BCS:HWM1

This article provides financial information for Howmet Aerospace Inc. (BCS:HWM1) on the Santiago Stock Exchange, specifically focusing on its price-to-book forward ratio. It appears to be a stub or data page from TradingView, offering an overview of the company's financials without detailed analysis.

₹524: That's What Analysts Think Awfis Space Solutions Limited (NSE:AWFIS) Is Worth After Its Latest Results

Analysts Have Made A Financial Statement On IndiQube Spaces Limited's (NSE:INDIQUBE) First-Quarter Report

Top York Space Systems (YSS) Competitors 2026

SpaceX Stock Is Down 33% From Its High. Elon Musk Expects Revenue to Rise 53-Fold to $1 Trillion by 2030.

Space Exploration Technologies (NASDAQ: SPCX) generated $18.7 billion in revenue in 2025. Chief Executive Officer Elon Musk just predicted that the company will hit $100 billion in annual recurring revenue (ARR) by the end of this year, and $1 trillion in revenue by 2030. …

This ETF Got You Into SpaceX Before the IPO. Now That Anyone Can Buy the Stock, What’s It For?

Quick Read SpaceX's IPO erased the NASA ETF's defining edge; SpaceX now represents only 7% of holdings, with Rocket Lab leading at 11% and the fund down 29% since June. LUNR cratered 50% and FLY dropped 40% since June while VSAT gained 14%, making …

Top Honeywell Aerospace (HONA) Competitors 2026

Shanghai Fudan Zhangjiang Bio Pharmaceutical Ltd (SEHK:1349) Stock Profit Rebound Raises Durability Questions

Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Eton Pharmaceuticals (NASDAQ: ETON) saw its shares rise significantly in pre-market trading after reporting stronger-than-expected second-quarter financial results and providing an optimistic revenue guidance for FY26. The company exceeded analyst consensus estimates for both earnings per share and sales. The article also lists other …

Is BioMarin Pharmaceutical (BMRN) Still Cheap As 2026 Guidance Rises And Amicus Adds Growth?

BioMarin Pharmaceutical (BMRN) has updated its 2026 guidance and completed the Amicus acquisition, leading to increased attention on the stock. Despite strong short-term momentum and a "22% Undervalued" narrative, the article highlights the need for investors to consider inherent risks, such as reliance on …

ETFs Investing in Regeneron Pharmaceuticals, Inc. Stocks

This article provides a comprehensive list of Exchange Traded Funds (ETFs) that invest in Regeneron Pharmaceuticals, Inc. (RGO) stocks. The list, sorted by market value, details each fund's symbol, market value, weight of RGO stock, issuer, management style, focus, expense ratio, assets under management …

Is Teva Pharmaceutical Industries (TEVA) A Bargain On Its TEV 408 Phase 2b Move?

ANI Pharmaceuticals (ANIP) Could Be 34% Undervalued As Earnings And Guidance Hold

ANI Pharmaceuticals (ANIP) is currently in focus after reporting its Q2 and H1 2026 results and reaffirming its full-year net revenue outlook of $1,080 million to $1,140 million. Despite recent strong earnings, the stock has seen a short-term decline, though it shows significant long-term …

Ionis Pharmaceuticals (IONS) Has A $92 Fair Value Narrative, Is The Stock A Bargain?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Ionis Pharmaceuticals (IONS) has drawn investor attention after recent share price moves, with the stock up over the past month but down over the past …

Price to book ratio of Howmet Aerospace Inc. – BCS:HWM1

This article displays the price-to-book ratio for Howmet Aerospace Inc. (HWM1) on the Santiago Stock Exchange, as provided by TradingView. It indicates that the market is closed and no trades have occurred. The content is primarily a data presentation with no additional analysis or …

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we are looking at …

Park Aerospace board chairman & CEO Brian Shore sells $2.84m in shares

Brian E. Shore, Chairman & CEO of Park Aerospace Corp., sold $2.84 million in company shares and acquired $980,400 worth of shares in August 2026 through option exercises and same-day sales. Following these transactions, Shore directly owns 621,369 shares and indirectly holds more through …

GE Aerospace CEO Says Company Well-Positioned To Navigate Dynamic Macro Environment

Howmet (HWM) Stock Looks 45% Expensive Despite Raised 2026 Guidance

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Howmet Aerospace stock is sitting near record levels after a very strong multi year run, yet the latest valuation work using a Discounted …

Eton Pharmaceuticals Stock Soars After Huge Q2 Beat And Target Hikes

Eton Pharmaceuticals (ETON) stock surged by 45.78% after reporting a significant Q2 beat, with non-GAAP EPS of $0.43 and revenue of $37.6M, driven by 99% year-over-year growth. The company also raised its 2026 revenue guidance to over $145M and adjusted EBITDA margin to at …

ASTS Stock Rises After-Hours — But Analyst Warns Every Starlink Weakness 'Is Worse' For AST SpaceMobile

Eton Pharmaceuticals Soars After Blowout Q2 And Guidance Hike

Eton Pharmaceuticals (NASDAQ: ETON) experienced a significant stock surge of over 45% after reporting blowout Q2 earnings and raising its 2026 revenue guidance. The company's Q2 non-GAAP EPS and revenue significantly beat consensus estimates, driven by strong growth and the successful relaunch of Hemangeol. …

Will Aurinia’s Reaffirmed 2026 Guidance and Large Buyback Reshape Aurinia Pharmaceuticals' (AUPH) Narrative?

Acumen Pharmaceuticals Inc (ABOS) Stock News Today

ASTS Stock Rises As Q1 Earnings Loom: Execs Tout Growing Government Demand And New Texas Factory’s Capacity

Honeywell Aerospace (HONA) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Chief Executive Officer - Jim Currier Chief Financial Officer - Josh Jepsen Vice President of Investor Relations - Sean Meakim Full Conference Call Transcript Operator: Thank you for …

Don't Ignore The Insider Selling In Rocket Pharmaceuticals

A Chief Operating Officer at Rocket Pharmaceuticals recently sold US$128k worth of shares, representing 6.8% of their holding. This sale was the largest insider sale in the past year, though it occurred around the current market price, making it less concerning than sales at …

Recursion Pharmaceuticals (RXRX) Stock Dropped, So What Is Behind The Move?

Xenon Pharmaceuticals Independent Director Steven Gannon Sells 84% Of Holding

Nasdaq Futures Lead US Premarket Rally As Iran Ceasefire Reports Ease Fears Ahead Of Big Tech Earnings: Why NVDA, ORCL, SPCX, XOM, OTLK Are In Focus

ASTS Stock Takes Biggest Hit In 2 Weeks: AST SpaceMobile Sticks To $1B Revenue Goal, Government May Bring Half